Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.20.2
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total revenues $ 2,477,782 $ 2,606,398 $ 5,593,376 $ 5,078,915
Product - Functional Neurosurgery        
Total revenues 1,049,015 1,690,122 2,733,424 3,294,767
Product - Biologics and Drug Delivery        
Total revenues 406,955 244,949 580,330 529,859
Products - Therapy        
Total revenues 21,300 17,830 78,800 17,830
Product - Capital Equipment        
Total revenues 115,800 241,293 303,901 515,692
Product Revenue        
Total revenues 1,593,070 2,194,194 3,696,455 4,358,148
Services - Capital Equipment and Other        
Total revenues 123,998 243,954 280,493 455,156
Services - Biologics and Drug Delivery        
Total revenues 760,714 168,250 1,616,428 265,611
Service and Other Revenues        
Total revenues $ 884,712 $ 412,204 $ 1,896,921 $ 720,767